Elle traite des conditions comme la maladie de décompression, les infections et les brûlures.
Maladie de décompressionInfections
#2
Comment se déroule une séance d'oxygénation ?
Une séance se déroule dans une chambre pressurisée où le patient respire de l'oxygène pur.
Chambre hyperbareThérapie
#3
Quelle est la durée d'une séance ?
Une séance dure généralement entre 60 et 120 minutes, selon la condition traitée.
Durée de traitementThérapie
#4
Y a-t-il des effets secondaires ?
Les effets secondaires peuvent inclure des douleurs aux oreilles, des nausées ou des troubles visuels.
Effets secondairesNausées
#5
Qui peut administrer ce traitement ?
Le traitement doit être administré par des professionnels de santé formés en médecine hyperbare.
Médecine hyperbareProfessionnels de santé
Complications
5
#1
Quelles complications peuvent survenir ?
Les complications incluent des lésions pulmonaires, des convulsions et des infections.
ComplicationsLésions pulmonaires
#2
Comment gérer une embolie gazeuse ?
Une embolie gazeuse nécessite une intervention rapide, souvent avec une oxygénation hyperbare.
Embolie gazeuseIntervention médicale
#3
Quels risques liés à l'oxygénation hyperbare ?
Les risques incluent des barotraumatismes, des troubles de la vision et des réactions allergiques.
BarotraumatismesRéactions allergiques
#4
Comment prévenir les infections en chambre ?
Pour prévenir les infections, maintenez une bonne hygiène et suivez les protocoles de désinfection.
InfectionsHygiène
#5
Quels signes d'une complication grave ?
Des signes comme des douleurs thoraciques intenses ou des troubles neurologiques nécessitent une attention immédiate.
Complications gravesTroubles neurologiques
Facteurs de risque
5
#1
Quels sont les facteurs de risque de décompression ?
Les facteurs incluent la profondeur de plongée, la durée et l'absence de pauses de sécurité.
Facteurs de risquePlongée
#2
Qui est à risque d'intoxication à l'oxygène ?
Les plongeurs et les patients recevant une oxygénation hyperbare à haute pression sont à risque.
Intoxication à l'oxygènePlongeurs
#3
Quels antécédents augmentent les risques ?
Des antécédents de troubles respiratoires ou neurologiques peuvent augmenter les risques.
Antécédents médicauxTroubles respiratoires
#4
Comment l'âge influence-t-il les risques ?
Les personnes âgées peuvent avoir un risque accru de complications en raison de la fragilité des tissus.
ÂgeComplications
#5
Quels médicaments augmentent les risques ?
Certains médicaments, comme les diurétiques, peuvent augmenter le risque de déshydratation et de complications.
MédicamentsDéshydratation
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Oxygénation hyperbare : Questions médicales les plus fréquentes",
"headline": "Oxygénation hyperbare : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Oxygénation hyperbare : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-26",
"dateModified": "2025-04-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Oxygénation hyperbare"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Oxygénothérapie",
"url": "https://questionsmedicales.fr/mesh/D010102",
"about": {
"@type": "MedicalCondition",
"name": "Oxygénothérapie",
"code": {
"@type": "MedicalCode",
"code": "D010102",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.880.690"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Oxygénation hyperbare",
"alternateName": "Hyperbaric Oxygenation",
"code": {
"@type": "MedicalCode",
"code": "D006931",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Richard E Moon",
"url": "https://questionsmedicales.fr/author/Richard%20E%20Moon",
"affiliation": {
"@type": "Organization",
"name": "Departments of Anesthesiology and Medicine, Center for Hyperbaric Medicine and Environmental Physiology, Duke University, North Carolina U.S."
}
},
{
"@type": "Person",
"name": "John P Kirby",
"url": "https://questionsmedicales.fr/author/John%20P%20Kirby",
"affiliation": {
"@type": "Organization",
"name": "John P. Kirby MD, FACS, is the Director of Wound Healing Programs, Associate Professor of Surgery, Section of Acute and Critical Care Surgery, at Washington University School of Medicine, Barnes-Jewish Hospital, in St. Louis, Missouri."
}
},
{
"@type": "Person",
"name": "Stephen R Thom",
"url": "https://questionsmedicales.fr/author/Stephen%20R%20Thom",
"affiliation": {
"@type": "Organization",
"name": "Emergency Medicine, University of Maryland, Baltimore, MD, USA."
}
},
{
"@type": "Person",
"name": "Michael H Bennett",
"url": "https://questionsmedicales.fr/author/Michael%20H%20Bennett",
"affiliation": {
"@type": "Organization",
"name": "Department of Diving and Hyperbaric Medicine, Prince of Wales Hospital and University of New South Wales, Sydney, New South Wales, Australia."
}
},
{
"@type": "Person",
"name": "Simon J Mitchell",
"url": "https://questionsmedicales.fr/author/Simon%20J%20Mitchell",
"affiliation": {
"@type": "Organization",
"name": "Department of Anaesthesiology, University of Auckland Faculty of Medicine, Auckland, New Zealand."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Epidemiology of Myopia: Prevalence, Risk Factors and Effects of Myopia.",
"datePublished": "2024-10-09",
"url": "https://questionsmedicales.fr/article/39384213",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2340-1790"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of myopia-associated genes in a Han Chinese population with high myopia.",
"datePublished": "2023-05-11",
"url": "https://questionsmedicales.fr/article/37165999",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/13816810.2023.2191709"
}
},
{
"@type": "ScholarlyArticle",
"name": "Extreme myopia is more susceptible to SOX2 gene than high myopia.",
"datePublished": "2023-03-14",
"url": "https://questionsmedicales.fr/article/36921835",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.exer.2023.109435"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prevalence of myopia and uncorrected myopia among 721 032 schoolchildren in a city-wide vision screening in southern China: the Shantou Myopia Study.",
"datePublished": "2023-11-22",
"url": "https://questionsmedicales.fr/article/36198476",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bjo-2021-320940"
}
},
{
"@type": "ScholarlyArticle",
"name": "EVO/EVO+ Visian Implantable Collamer Lenses for the correction of myopia and myopia with astigmatism.",
"datePublished": "2023-02-10",
"url": "https://questionsmedicales.fr/article/36708714",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/17434440.2023.2174429"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Thérapeutique",
"item": "https://questionsmedicales.fr/mesh/D013812"
},
{
"@type": "ListItem",
"position": 3,
"name": "Thérapie respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012138"
},
{
"@type": "ListItem",
"position": 4,
"name": "Oxygénothérapie",
"item": "https://questionsmedicales.fr/mesh/D010102"
},
{
"@type": "ListItem",
"position": 5,
"name": "Oxygénation hyperbare",
"item": "https://questionsmedicales.fr/mesh/D006931"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Oxygénation hyperbare - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Oxygénation hyperbare",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Oxygénation hyperbare",
"description": "Comment diagnostiquer une décompression ?\nQuels tests pour l'oxygénation hyperbare ?\nQuels symptômes indiquent un traitement ?\nComment évaluer l'efficacité du traitement ?\nQuels critères pour l'admission en chambre hyperbare ?",
"url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=Myopia#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Oxygénation hyperbare",
"description": "Quels sont les symptômes de l'oxygénation hyperbare ?\nComment se manifeste l'intoxication à l'oxygène ?\nQuels signes d'une embolie gazeuse ?\nQuels symptômes après une séance d'oxygénation ?\nComment reconnaître une réaction allergique ?",
"url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=Myopia#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Oxygénation hyperbare",
"description": "Comment prévenir la maladie de décompression ?\nQuelles précautions avant une séance ?\nComment éviter l'intoxication à l'oxygène ?\nQuelles sont les recommandations post-traitement ?\nComment se préparer psychologiquement ?",
"url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=Myopia#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Oxygénation hyperbare",
"description": "Quelles conditions traitent l'oxygénation hyperbare ?\nComment se déroule une séance d'oxygénation ?\nQuelle est la durée d'une séance ?\nY a-t-il des effets secondaires ?\nQui peut administrer ce traitement ?",
"url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=Myopia#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Oxygénation hyperbare",
"description": "Quelles complications peuvent survenir ?\nComment gérer une embolie gazeuse ?\nQuels risques liés à l'oxygénation hyperbare ?\nComment prévenir les infections en chambre ?\nQuels signes d'une complication grave ?",
"url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=Myopia#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Oxygénation hyperbare",
"description": "Quels sont les facteurs de risque de décompression ?\nQui est à risque d'intoxication à l'oxygène ?\nQuels antécédents augmentent les risques ?\nComment l'âge influence-t-il les risques ?\nQuels médicaments augmentent les risques ?",
"url": "https://questionsmedicales.fr/mesh/D006931?mesh_terms=Myopia#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une décompression ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic de décompression se fait par l'évaluation des symptômes et des antécédents d'immersion."
}
},
{
"@type": "Question",
"name": "Quels tests pour l'oxygénation hyperbare ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie et des évaluations cliniques sont utilisés pour déterminer l'indication."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un traitement ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des douleurs articulaires, des troubles neurologiques ou des brûlures peuvent indiquer un traitement."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité du traitement ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par l'amélioration des symptômes et des tests de suivi après traitement."
}
},
{
"@type": "Question",
"name": "Quels critères pour l'admission en chambre hyperbare ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent des conditions médicales spécifiques et l'absence de contre-indications."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'oxygénation hyperbare ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des douleurs, des vertiges, et des troubles de la vision."
}
},
{
"@type": "Question",
"name": "Comment se manifeste l'intoxication à l'oxygène ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'intoxication à l'oxygène se manifeste par des convulsions, des nausées et des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Quels signes d'une embolie gazeuse ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des douleurs thoraciques, des difficultés respiratoires et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes après une séance d'oxygénation ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Après une séance, des sensations de fatigue ou de légers maux de tête peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une réaction allergique peut se manifester par des éruptions cutanées, des démangeaisons ou un gonflement."
}
},
{
"@type": "Question",
"name": "Comment prévenir la maladie de décompression ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut une ascension lente après la plongée et des pauses de sécurité."
}
},
{
"@type": "Question",
"name": "Quelles précautions avant une séance ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez de fumer, de consommer de l'alcool et informez le médecin de vos antécédents médicaux."
}
},
{
"@type": "Question",
"name": "Comment éviter l'intoxication à l'oxygène ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pour éviter l'intoxication, respectez les protocoles de traitement et les durées recommandées."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations post-traitement ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Après traitement, reposez-vous et évitez les activités physiques intenses pendant 24 heures."
}
},
{
"@type": "Question",
"name": "Comment se préparer psychologiquement ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Préparez-vous en vous informant sur le traitement et en discutant avec des professionnels."
}
},
{
"@type": "Question",
"name": "Quelles conditions traitent l'oxygénation hyperbare ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle traite des conditions comme la maladie de décompression, les infections et les brûlures."
}
},
{
"@type": "Question",
"name": "Comment se déroule une séance d'oxygénation ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une séance se déroule dans une chambre pressurisée où le patient respire de l'oxygène pur."
}
},
{
"@type": "Question",
"name": "Quelle est la durée d'une séance ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une séance dure généralement entre 60 et 120 minutes, selon la condition traitée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des douleurs aux oreilles, des nausées ou des troubles visuels."
}
},
{
"@type": "Question",
"name": "Qui peut administrer ce traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement doit être administré par des professionnels de santé formés en médecine hyperbare."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions pulmonaires, des convulsions et des infections."
}
},
{
"@type": "Question",
"name": "Comment gérer une embolie gazeuse ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une embolie gazeuse nécessite une intervention rapide, souvent avec une oxygénation hyperbare."
}
},
{
"@type": "Question",
"name": "Quels risques liés à l'oxygénation hyperbare ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent des barotraumatismes, des troubles de la vision et des réactions allergiques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections en chambre ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pour prévenir les infections, maintenez une bonne hygiène et suivez les protocoles de désinfection."
}
},
{
"@type": "Question",
"name": "Quels signes d'une complication grave ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des douleurs thoraciques intenses ou des troubles neurologiques nécessitent une attention immédiate."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de décompression ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent la profondeur de plongée, la durée et l'absence de pauses de sécurité."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'intoxication à l'oxygène ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les plongeurs et les patients recevant une oxygénation hyperbare à haute pression sont à risque."
}
},
{
"@type": "Question",
"name": "Quels antécédents augmentent les risques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents de troubles respiratoires ou neurologiques peuvent augmenter les risques."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il les risques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées peuvent avoir un risque accru de complications en raison de la fragilité des tissus."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent les risques ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments, comme les diurétiques, peuvent augmenter le risque de déshydratation et de complications."
}
}
]
}
]
}
John P. Kirby MD, FACS, is the Director of Wound Healing Programs, Associate Professor of Surgery, Section of Acute and Critical Care Surgery, at Washington University School of Medicine, Barnes-Jewish Hospital, in St. Louis, Missouri.
Department of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital and Department of Immunology and Microbiology (ISIM), University of Copenhagen, Denmark.
Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet and Department of Immunology and Microbiology (ISIM), University of Copenhagen, Denmark.
Myopia is the most common cause of visual impairment in children and young adults. In order to assess the consequences for society, it is necessary to know temporal trends in prevalence, incidence and...
High myopia is a leading cause of blindness worldwide. However, the exact etiology and mechanism of high myopia remain unclear. Previous genome-wide association study has demonstrated that nine single...
Seven SNPs were genotyped by the MassARRAY iPLEX Gold method in a Han Chinese cohort with the majority from Henan region (central China), which included 361 patients with high myopia and 749 healthy c...
In terms of genotyped SNPs, the allele frequency of rs698047 locus of the HIVEP3 gene were statistically different between myopia and control groups initially, but the difference disappeared after Bon...
There was no demonstrated association between the occurrence of high myopia in the Chinese Han population and polymorphisms in the following loci: HIVEP3 (rs698047), NFASC/CNTN2 (rs2246661), ZC3H11B (...
To explore the association between two single-nucleotide polymorphisms (SNPs) in the SOX2 gene and high and extreme myopia in the Han Chinese population....
A genetic association study using a case-control method was performed with 139 high myopia, 318 extreme myopia, and 918 healthy participants from the Chinese Han population. Two SNPs (rs4459940 and rs...
The mean ages of the extreme myopia and control subjects were 47.44 ± 15.59 and 44.15 ± 14.08 years, respectively. The rs4575941 SNP of the SOX2 gene and the GG and AG genotypes showed no significant ...
The SOX2 rs4575941 polymorphism, in Chinese Han population, contributes to the susceptibility of extreme myopia. SOX2 may thus be implicated in extreme myopia rather than in high myopia....
To explore the prevalence and risk factors for myopia and uncorrected myopia in schoolchildren in southern China....
The government-led Shantou Myopia Study was conducted from September 2020 to June 2021. Non-cycloplegic refraction was performed. Uncorrected visual acuity (UCVA) was measured along with presenting vi...
This study enrolled 724 828 schoolchildren (77.8% of all schoolchildren in Shantou) from 901 schools. Data from 721 032 schoolchildren (99.5%) were analysed (mean age 11.53±3.13 years, 6-20 years, 373...
The overall prevalence of myopia among schoolchildren in Shantou was 51.8%, higher than the national average in China. The proportion of uncorrected myopia is high, especially in primary schools. Our ...
Intraocular lens implantation in phakic eyes for the correction of refractive error is currently a widespread procedure. The EVO and EVO+ Visian Implantable Collamer Lenses (ICL) are two of the most p...
During the last decade, more than 100 scientific papers analyzing the performance of EVO and EVO+ lenses have been published. This review describes the objective visual performance achieved with the i...
Refractive surgeons and candidates to undergo ICL implantation should be aware of the excellent safety and visual outcomes provided by the implantation of central hole ICL lenses. However, future rese...
Initial studies have suggested that multiple segment (MS) spectacle lenses can reduce the progression rate of childhood myopia and axial eye growth. This paper aimed to compare the effectiveness of tw...
Published data from the only two clinical trials in which changes in mean spherical equivalent refraction (SER) and axial length (AL) for matched groups of myopic children wearing either MS or single-...
Absolute changes in SER and AL differed over time during the two trials. However, if the results were expressed in terms of efficacy over successive 6-month periods, then the two MS lenses produced br...
Myopia control may be due to either the additional myopic defocus induced by the MS lenses (i.e., asymmetry of the through-focus image changes about the distance focus) or to the general reduction in ...
Multiple segment spectacle lenses offer a valuable new approach to the control of myopia progression in children. Further work is required to clarify their mechanism of action and to optimise their de...
This study is a retrospective analysis to compare ocular biometry measurements of axial length in children with myopia using Myopia Master (OCULUS, Wetzlar, Germany) and Lenstar LS900 (HAAG-STREIT AG,...
Axial length measurements obtained with both instruments within a 3-week period were collected retrospectively. Measurements were visualized with a Bland-Altman plot. For statistical evaluation, a pai...
Sixty-one eyes from 31 myopic patients (59% male, 41% female) with a mean age of 11.34 ± 3.25 years (range: 6 - 18 years) were identified. Mean axial length was 24.7 mm (SD 1.29) with the Myopia Maste...
The axial length measured by Myopia Master and Lenstar LS900 did not differ significantly. Thus, previous values obtained with the Lenstar LS900 can be applied to assess myopia progression....
The META-Analysis of Pathologic Myopia Study group proposed a new classification system for myopic maculopathy (MM) with pathologic myopia (PM) defined as MM equal to/more serious than diffuse atrophy...
This study examined the optical impact of a DF contact lens during near viewing in a sample of habitual DF lens wearing children....
Seventeen myopic children aged 14 to 18 years who had completed 3 or 6 years of treatment with a DF contact lens (MiSight 1 Day; CooperVision, Inc., San Ramon, CA) were recruited and fit bilaterally w...
During near viewing, children wearing single-vision lenses accommodated on average to achieve approximate focus in the pupil center but, because of combined accommodative lag and negative spherical ab...
The DF contact lens did not alter the accommodative behavior of children. The treatment optics introduced myopic defocus and decreased the amount of hyperopically defocused light in the retinal image....
The rising prevalence of myopia among children and adolescents necessitates effective interventions to mitigate long-term risks, such as retinal detachment and macular degeneration. Traditional approa...